Breaking News Instant updates and real-time market news.

CLVS

Clovis

$32.14

2.985 (10.24%)

10:53
10/02/18
10/02
10:53
10/02/18
10:53

JPMorgan increasingly confident in Clovis Oncology's rucaparib

JPMorgan analyst Cory Kasimov is encouraged by Clovis Oncology's announcement this morning that rucaparib received breakthrough designation from the FDA for the third line treatment of patients with BRCA mutated metastatic castrate-resistant prostate cancer on the basis of data from the Triton-2 study. The analyst says the news further increases his confidence in the potential for rucaparib to produce response rates that are meaningfully better than currently available options. His model implies $9 per share for prostate, assuming a 55% probability of success and $450M in peak unadjusted sales. Kasimov keeps an Overweight rating on Clovis, which is up 11%, or $3.33, to $32.47 in morning trading.

CLVS Clovis
$32.14

2.985 (10.24%)

09/17/18
PIPR
09/17/18
NO CHANGE
Target $35
PIPR
Neutral
Piper sees Astra's Lynparza as 'much cleaner' than Tesaro's Zejula
Piper Jaffray analyst Christopher Raymond reiterates a Neutral rating and $35 price target on Tesaro (TSRO) after analyzing a year's worth of adverse event reporting as captured by FDA's Adverse Event Reporting System database, which he obtained through a Freedom of Information Act request. The analyst, while cautioning that the database "likely contains inaccuracies and is far from perfect," is "struck by how much cleaner" AstraZeneca's (AZN) Lynparza appears versus Tesaro's Zejula and Clovis Oncology's (CLVS) Rubraca. Further, Raymond is also surprised that Zejula's adverse events rates do not appear to have decreased in any meaningful way year-over-year, despite Tesaro's active down-dosing efforts. Since the analyst thinks PARPi differentiation remains largely around safety, he lowered his Zejula estimates in 2019 and beyond. Lynparza is likely to maintain the upper hand, Raymond tells investors in a research note.
09/17/18
GUGG
09/17/18
INITIATION
Target $75
GUGG
Buy
Clovis initiated with a Buy at Guggenheim
Target $75.
09/21/18
JPMS
09/21/18
NO CHANGE
Target $71
JPMS
Overweight
Clovis price target lowered to $71 from $87 at JPMorgan
JPMorgan analyst Cory Kasimov lowered his price target for Clovis Oncology to $71 after "reigning in" his ovarian expectations but keeps an Overweight rating on the shares. With the European Society of Medical Oncology meeting coming up in October, Kasimov is previewing the first look at data from Clovis's Triton-2 study in prostate cancer. The analyst is "quite confident" that the company's PARP inhibitor rucaparib should produce response rates that are well above chemotherapy and anti-androgens, at least in third line BRCA positive patients. He views the Triton-2 update as an important event for Clovis and believes "promising results could represent a step towards restoring more favorable sentiment." A response rate of at least 30% is the lower bar for share appreciation, Kasimov tells investors in a research note. He keeps an Overweight rating on Clovis.
09/24/18
LEER
09/24/18
INITIATION
Target $30
LEER
Market Perform
Clovis initiated with a Market Perform at Leerink
Leerink analyst Andrew Berens started Clovis Oncology with a Market Perform rating and $30 price target.

TODAY'S FREE FLY STORIES

SLM

Sallie Mae

$10.58

(0.00%)

17:19
10/22/18
10/22
17:19
10/22/18
17:19
Earnings
Sallie Mae reports Q3 adjusted EPS 23c, consensus 24c »

Reports Q3 NII $356.6M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 06

    Nov

BA

Boeing

$355.98

-0.3 (-0.08%)

17:17
10/22/18
10/22
17:17
10/22/18
17:17
Hot Stocks
Correction: Boeing maintains quarterly dividend of $1.71 »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

JOE

Saint Joe Co.

$15.08

-0.14 (-0.92%)

, MAR

Marriott

$111.49

-0.58 (-0.52%)

17:15
10/22/18
10/22
17:15
10/22/18
17:15
Hot Stocks
St. Joe Company, InterMountain break ground on New Towneplace Suites Hotel »

The St. Joe Company (JOE)…

JOE

Saint Joe Co.

$15.08

-0.14 (-0.92%)

MAR

Marriott

$111.49

-0.58 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

RNST

Renasant

$35.44

-1.1 (-3.01%)

17:11
10/22/18
10/22
17:11
10/22/18
17:11
Earnings
Renasant reports Q3 adjusted EPS 61c, consensus 77c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 06

    Dec

IAG

IAMGold

$3.84

-0.13 (-3.27%)

17:09
10/22/18
10/22
17:09
10/22/18
17:09
Hot Stocks
IAMGold announces positive results from a feasibility study for Senegal project »

IAMGOLD announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

HWBK

Hawthorn Bancshares

$23.20

-0.27 (-1.15%)

17:09
10/22/18
10/22
17:09
10/22/18
17:09
Hot Stocks
Breaking Hot Stocks news story on Hawthorn Bancshares »

Endeavour Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNBC

Green Bancorp

$19.34

-0.7 (-3.49%)

17:07
10/22/18
10/22
17:07
10/22/18
17:07
Earnings
Green Bancorp reports Q3 EPS 49c, consensus 47c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

VBTX

Veritex

$24.43

-1.07 (-4.20%)

17:06
10/22/18
10/22
17:06
10/22/18
17:06
Earnings
Veritex reports Q3 core EPS 34c, consensus 46c »

Reports Q3 tangible book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

IBTX

Independent Bank

$56.47

-3.06 (-5.14%)

17:04
10/22/18
10/22
17:04
10/22/18
17:04
Earnings
Independent Bank reports Q3 EPS $1.20, consensus $1.20 »

Net interest income was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

BRO

Brown & Brown

$29.12

0.27 (0.94%)

17:03
10/22/18
10/22
17:03
10/22/18
17:03
Hot Stocks
Breaking Hot Stocks news story on Brown & Brown »

Brown & Brown reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 02

    Nov

  • 14

    Nov

SFNC

Simmons First National

$25.62

-0.78 (-2.95%)

17:03
10/22/18
10/22
17:03
10/22/18
17:03
Hot Stocks
Breaking Hot Stocks news story on Simmons First National »

Simmons First National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 26

    Nov

CR

Crane

$87.33

-0.28 (-0.32%)

17:03
10/22/18
10/22
17:03
10/22/18
17:03
Earnings
Crane raises FY18 EPS ex-items view to $5.80-$5.90 from $5.60-$5.80 »

Consensus $5.75. Raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 05

    Dec

  • 06

    Dec

GNBC

Green Bancorp

$19.34

-0.7 (-3.49%)

17:02
10/22/18
10/22
17:02
10/22/18
17:02
Earnings
Green Bancorp reports Q3 non-GAAP EPS 49c, consensus 47c »

Reports Q3 provision for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

SFNC

Simmons First National

$25.62

-0.78 (-2.95%)

17:02
10/22/18
10/22
17:02
10/22/18
17:02
Earnings
Simmons First National reports Q3 core EPS 61c, consensus 58c »

Reports Q3 net interest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 26

    Nov

CR

Crane

$87.33

-0.28 (-0.32%)

17:02
10/22/18
10/22
17:02
10/22/18
17:02
Earnings
Crane reports Q3 EPS ex-items $1.62, consensus $1.46 »

Reports Q3 revenue $856M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 05

    Dec

  • 06

    Dec

BRO

Brown & Brown

$29.12

0.27 (0.94%)

17:01
10/22/18
10/22
17:01
10/22/18
17:01
Earnings
Brown & Brown reports Q3 adjusted EPS 38c, consensus 34c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 02

    Nov

  • 14

    Nov

NBTB

NBT Bancorp

$36.29

-0.57 (-1.55%)

16:54
10/22/18
10/22
16:54
10/22/18
16:54
Hot Stocks
NBT Bancorp raises quarterly dividend to 26c from 25c per share »

The dividend will be paid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBTB

NBT Bancorp

$36.29

-0.57 (-1.55%)

16:54
10/22/18
10/22
16:54
10/22/18
16:54
Earnings
NBT Bancorp reports Q3 adjusted EPS 68c, consensus 65c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PERY

Perry Ellis

$27.50

(0.00%)

16:51
10/22/18
10/22
16:51
10/22/18
16:51
Hot Stocks
Perry Ellis announces completion of its acquisition in $437M transaction »

Perry Ellis International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

FBK

FB Financial

$33.54

-1.36 (-3.90%)

16:51
10/22/18
10/22
16:51
10/22/18
16:51
Earnings
FB Financial reports Q3 adjusted EPS 68c, consensus 72c »

President and Chief…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 05

    Nov

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

  • 05

    Dec

  • 06

    Dec

FBK

FB Financial

$33.54

-1.36 (-3.90%)

16:49
10/22/18
10/22
16:49
10/22/18
16:49
Hot Stocks
FB Financial authorizes $50M common stock repurchase program »

FB Financial's board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 05

    Nov

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

  • 05

    Dec

  • 06

    Dec

FBK

FB Financial

$33.54

-1.36 (-3.90%)

16:48
10/22/18
10/22
16:48
10/22/18
16:48
Hot Stocks
FB Financial increases quarterly dividend 33% »

FB Financial Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 05

    Nov

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

  • 05

    Dec

  • 06

    Dec

SSB

South State

$73.05

-1.975 (-2.63%)

16:48
10/22/18
10/22
16:48
10/22/18
16:48
Earnings
South State reports Q3 adjusted EPS $1.33, consensus $1.40 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UVE

Universal Insurance

$47.72

0.72 (1.53%)

16:47
10/22/18
10/22
16:47
10/22/18
16:47
Hot Stocks
Universal Insurance announces expected financial impact from weather events »

Universal Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

HLT

Hilton

$70.17

-0.49 (-0.69%)

16:47
10/22/18
10/22
16:47
10/22/18
16:47
Initiation
Hilton initiated  »

Hilton initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.